Pharming Group N.V. (NASDAQ:PHAR) reported preliminary, unaudited full-year 2025 revenues of approximately $376 million, topping its own recently elevated guidance and marking a 27% increase over 2024.
Evotec SE (NASDAQ:EVO) announced that its Seattle-based subsidiary, Just – Evotec Biologics, has received a new grant (INV072135) from the Bill & Melinda Gates Foundation to accelerate the development of affordable biologics for low- and middle-income countries.
Shell (NYSE:SHEL) signaled a challenging end to 2025, warning that its chemicals business will likely fall below break-even despite maintaining steady output in its core oil and gas segments.
CME Group (NYSE:CME) reported that its international trading volume reached a historic high in 2025, as a surge in metals and equity index demand offset a stabilizing landscape in Latin America.
China’s interest-bearing digital yuan is fuelling fears the US may be falling behind in the global race for digital money.
Bitwise says legislative progress and market stability will decide whether crypto hits new records in 2026.
The fatal shooting of a woman by a US immigration agent in Minneapolis has triggered protests and calls for accountability.
Anthropic is seeking $10bn in new funding that could nearly double its valuation to $350bn.
US forces have seized two tankers accused of moving sanctioned Venezuelan oil in global enforcement operations.
Memecoins are regaining attention as social buzz and trading activity point to renewed risk appetite in crypto markets.
Crypto executives say altering the GENIUS Act could damage US competitiveness and create national security risks.
Ray Dalio said inflation-driven voter backlash in 2026 could undo Trump-era policies and stall crypto regulation.
-640x358.jpg&w=3840&q=75)
-640x358.jpg&w=3840&q=75)
-640x358.jpg&w=3840&q=75)
